Skip to main content

Afatinib 20mg | Afatinib 20mg tablet | Xovoltib | Apple pharmaceuticals

Afatinib 20mg | Afatinib 20mg tablet 
 Apple pharmaceuticals



Afatinib 20mg tablet

Xovoltib 20mg belongs to quinazoline and butanamide derivative which acts as a tyrosine kinase inhibitor of epidermal growth factor receptors (ERBB RECEPTORS) and is used in the treatment of metastatic NON-SMALL CELL LUNG CANCER.
Xovoltib 20mg is a prescription drugs which is used under the guidance of medical practioners.

INDICATION


Xovoltib 20mg is indicated for treatment a certain type of lung cancer (non-small cell lung cancer) which has spread to other parts of the body.

DOSAGE


Xovoltib the prescribed dose for the treatment of non-small cell lung cancer as follows :
For adult :
The prescribed dose is 40mg taken once per day.
For child dosage :
Ages of 0-17 years is not being studied in children.
The drug should not be used age under 18 years of age
For renal impairment:
prescribed dose is 30mg taken once per day
Take Xovoltib on an empty stomach. Consume the drug 1 hour before or 2 hours after a meal
Avoid cutting or crushing the tablet.

MECHANISM


Xovoltib 20mg blocking the activating sites called tyrosine kinases of various proteins within the cell. These proteins are most likely to develop cancer growth when the tumor includes the EGFR gene mutation. By stopping these targets, it will target the cancer will shrink.


PRECAUTIONS


Diarrhae:
mostnormal condition for people administrating this drug to have diarrhea. Certain situation this diarrhea can be serious. Severe diarrhea can cause dehydration and renal problems which can sometimes lead to death. During your treatment with Xovoltib 20mg, your doctor should also to treat diarrhea primarily.
Hepatic toxicity : Xovoltib 20mg can worsen liver problems. Doctor will take blood tests to monitor the liver function before and during your treatment with this drug.
Keratitis: if patients confirm with suspected keratitis or ulcerative keratitis then stop or discontinue the drug
Interstitial lung disease (ILD) : Xovoltib 20mg drug can leads to lung and breathing problems. Inform doctor right away about new or worsening lung problems while taking this drug. These problems can involveDyspnea, cough, or fever.
Bullous and exfoliative skin disorder : Xovoltib 20mg can affect skin severely and show redness, rash, and acne. Inform doctor right away if you affected by severe skin reactions such as peeling or blistering.
Embryo-fetal toxicity:
Xovoltib 20mg will cause harm to the foetus when administrated to pregnant women.


DRUG INTERACTION



Concomitant of Xovoltib 20mg with P-gpinhibitors (cyclosporine A, ketoconazole verapamil) will increase exposure to Afatinib
Interaction of Xovoltib 20mg with P-gpinducers (carbamazepine, phenytoin, phenobarbital) will decrease exposure to Afatinib


STORAGE


Xovoltib 20mg Store at 25℃.
Keep Xovoltib 20mg away from children.


MISSED DOSE


If patient missed to take the dose of Xovoltib 20mg,the missed dose should be skipped and follow the regular dosing schedule. Do not self-medicate. Do not double the dose.


SIDE EFFECTS


• Loss of appetite
• Nausea
• Vomiting
• Diarrhoea
• Mouth sores
• Acne
• Itchiness
• Rash
• Dry skin
• Nail infection
Serious side effects :
• Breathing trouble
• Cough and fever
• Yellowing the skins
• Brown coloured urine
• Bleeding or bruising
• Weakness
• Blurred vision
• Fast heartbeat

Contact Us


phone No      :9987711567

Email             :info@myapplepharma.com


website         

https://myapplepharma.com/afatinib-20mg.php

Comments

  1. Thanks for sharing such a beautiful information about Afatinib 20mg.


    See more details here ::: Afatinib 40 mg

    ReplyDelete

Post a Comment

Popular posts from this blog

Olimab 60mg injection | Denosumab 60mg |Apple pharmaceuticals

Olimab 60mg injection | Denosumab 60mg Apple pharmaceuticals Olimab 60mg | Olimab 60mg injection | Denosumab 60mg | Denosumab 60mg tablet Olimab 60mg injection ( Denosumab ) Olimab 60mg  belongs to novel, fully human IgG2 monoclonal antibody especially to receptor activator of nuclear factor kappa-B ligand (RANKL), restrain bone resorption markers in patients with a difference of metastatic tumors and is being examined in multiple clinical trials for the  Olimab 60mg   inhibition and treatment of bone metastases. Chemically, it exists of 2 heavy and 2 light chains. Each light chain contains of 215 amino acids. Each heavy chain contains of 448 amino acids with  Olimab 60mg   4 intramolecular disulfides. PRESCRIBED Treatment for patients having postmenopausal women with  Olimab 60mg   osteoporosis at high risk for fracture. Treatment for patients with increase bone mass in men at more risk for fracture getting androgen deprivation therapy for non-metastatic pros

Lynparza 50mg | Lynparza 50mg Capsules | Apple Pharmaceuticals

Lynparza 50mg | Lynparza 50mg Capsules   Apple Pharmaceuticals Lynparza 50mg   | Lynparza 50mg capsules |   Olaparib 50mg | Olaparib 50mg capsules Lynparza 50mg Capsules (Olaparib 50mg)   Lynparza                                                             Lynparza  is a type of targeted therapy called a PARP (oral poly (adenosine diphosphate–ribose) polymerase inhibitor)which has promising anti neoplasticaction in patients with metastatic breast cancer and a germline BRCA mutation. Lynparza 50mg  is an enzyme included in DNA repair and will act against cancers in people with hereditary BRCA1 or BRCA2 mutations, which involve some ovarian, breast and prostate cancer Lynparza 50mg Capsules  is a prescription drug which used under the supervision of medical practioners INDICATION Lynparza 50mg capsules Lynparza 50 capsules  is used for the treatment in patients with first line maintenance BRCAm advanced ovarian cancer Lynparza 50mg  is us

IKGDAR 100MG INJECTION | Rituximab | Apple pharmaceuticals

IKGDAR 100MG INJECTION | Rituximab  Apple pharmaceuticals ikgdar 100mg | ikgdar 100mg injection  |  Rituximab 100mg | rituximab 100mg injection Description ikgdar 100mg  is a anticancer medicine which prevents the growth and spread of cancer cells in the body, the main ingredient which is used as  rituximab .  ikgdar 100mg injection  will help to prevent the Non- Hodgkins lymphoma or chronic lymphocytic and with combination with another anticancer drugs like methotrexate is used for rheumatoid arthritis symptoms in adult treatment.  ikgdar 100mg  with steroid regimen combination is given for the treatment of some rare disorders which cause blood vessels and other tissues inflammation in the body. INDICATION Ikgdar 100mg  and hyaluronidase human injection are given alone or combination with another drugs to treat certain types of non-Hodgkin's lymphoma and chronic lymphocytic leukemia (cancer start in WBC).  Ikgdar 100mg  injection combination with methotrexate